Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Diazoxide enhances excitotoxicity-induced neurogenesis and attenuates neurodegeneration in the rat non-neurogenic hippocampus.

Martínez-Moreno M, Batlle M, Ortega FJ, Gimeno-Bayón J, Andrade C, Mahy N, Rodríguez MJ.

Neuroscience. 2016 Oct 1;333:229-43. doi: 10.1016/j.neuroscience.2016.07.032. Epub 2016 Jul 25.

2.

Amyloid-β immunotherapy reduces amyloid plaques and astroglial reaction in aged domestic dogs.

Neus Bosch M, Pugliese M, Andrade C, Gimeno-Bayón J, Mahy N, Rodriguez MJ.

Neurodegener Dis. 2015;15(1):24-37. doi: 10.1159/000368672. Epub 2014 Dec 20.

3.

Glucose pathways adaptation supports acquisition of activated microglia phenotype.

Gimeno-Bayón J, López-López A, Rodríguez MJ, Mahy N.

J Neurosci Res. 2014 Jun;92(6):723-31. doi: 10.1002/jnr.23356. Epub 2014 Feb 7.

PMID:
24510633
4.

Rapid improvement of canine cognitive dysfunction with immunotherapy designed for Alzheimer's disease.

Bosch MN, Gimeno-Bayón J, Rodríguez MJ, Pugliese M, Mahy N.

Curr Alzheimer Res. 2013 Jun;10(5):482-93.

PMID:
23566345
5.

ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats.

Ortega FJ, Gimeno-Bayon J, Espinosa-Parrilla JF, Carrasco JL, Batlle M, Pugliese M, Mahy N, Rodríguez MJ.

Exp Neurol. 2012 May;235(1):282-96. doi: 10.1016/j.expneurol.2012.02.010. Epub 2012 Feb 24.

6.

Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.

Virgili N, Espinosa-Parrilla JF, Mancera P, Pastén-Zamorano A, Gimeno-Bayon J, Rodríguez MJ, Mahy N, Pugliese M.

J Neuroinflammation. 2011 Nov 2;8:149. doi: 10.1186/1742-2094-8-149.

7.

Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease.

Bosch MN, Pugliese M, Gimeno-Bayón J, Rodríguez MJ, Mahy N.

Curr Alzheimer Res. 2012 Mar;9(3):298-314. Review.

PMID:
21875411
8.

Alzheimer's disease modifies progenitor cell expression of monoamine oxidase B in the subventricular zone.

Pugliese M, Rodríguez MJ, Gimeno-Bayon J, Pujadas L, Billett EE, Wells C, Mahy N.

J Neurosci Res. 2010 Sep;88(12):2588-97. doi: 10.1002/jnr.22423.

PMID:
20648649
9.

Fatal liver failure: molecular evidence for chronic active Epstein-Barr virus infection.

Sánchez F, Gimeno-Bayón JL, Esgueva R, Alvarez F, Munné MA, Serrano S.

Ann Diagn Pathol. 2008 Oct;12(5):368-71. doi: 10.1016/j.anndiagpath.2007.01.008. Epub 2007 Oct 18.

PMID:
18774502
10.

Subclinical carotid atherosclerosis in HIV-infected patients: role of combination antiretroviral therapy.

Jericó C, Knobel H, Calvo N, Sorli ML, Guelar A, Gimeno-Bayón JL, Saballs P, López-Colomés JL, Pedro-Botet J.

Stroke. 2006 Mar;37(3):812-7. Epub 2006 Jan 26.

PMID:
16439699
11.

[Candidemia in AIDS. A retrospective study of nine cases].

Saballs-Radresa P, Torres-Rodríguez JM, Salvadó M, Sales P, Gimeno-Bayón JL, Knobel H, López-Colomés JL, Serrano C, Drobnic L.

Rev Iberoam Micol. 2000 Mar;17(1):2-5. Spanish.

12.

Ritonavir-induced carbamazepine toxicity.

Mateu-de Antonio J, Grau S, Gimeno-Bayón JL, Carmona A.

Ann Pharmacother. 2001 Jan;35(1):125-6. No abstract available.

PMID:
11197575
13.

[Syphilitic arthro-osteitis].

Blanch J, Faus S, Gimeno-Bayón JL, Martínez-Pardo S, Benito P, Duró JC.

Med Clin (Barc). 1990 Apr 7;94(13):502-4. Spanish.

PMID:
2355765

Supplemental Content

Loading ...
Support Center